首页|PBAF loss leads to DNA damage-induced inflammatory signaling through defective G2/M checkpoint maintenance
PBAF loss leads to DNA damage-induced inflammatory signaling through defective G2/M checkpoint maintenance
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
The PBRM1 subunit of the PBAF (SWI/SNF) chromatin remodeling complex is mutated in ~40% of clear cell renal cancers. PBRM1 loss has been implicated in responses to immunotherapy in renal cancer, but the mechanism is unclear. DNA damage-induced inflammatory signaling is an important factor determining immunotherapy response. This response is kept in check by the G2/M checkpoint, which prevents progression through mitosis with unrepaired damage. We found that in the absence of PBRM1, p53-dependent p21 up-regulation is delayed after DNA damage, leading to defective transcriptional repression by the DREAM complex and premature entry into mitosis. Consequently, DNA damage-induced inflammatory signaling pathways are activated by cytosolic DNA. Notably, p53 is infrequently mutated in renal cancer, so PBRM1 mutational status is critical to G2/M checkpoint maintenance. Moreover, we found that the ability of PBRM1 deficiency to predict response to immunotherapy correlates with expression of the cytosolic DNA-sensing pathway in clinical samples. These findings have implications for therapeutic responses in renal cancer.
NSTL
